Skip to main content
OpenTrials

Clinical trial condition

Mantle Cell Lymphoma (MCL)

Explore clinical trials studying Mantle Cell Lymphoma (MCL). Study availability and eligibility vary by location and protocol.

36 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Mantle Cell Lymphoma (MCL) trial results

Recruiting

REal World Data in LYmphoma and Survival in Adults

NCT03869619

Conditions
Burkitt Lymphoma, Burkitt Lymphoma (BL)), DNA Virus Infections, +26 more
Locations
  • Unité d'Hématologie Clinique, CH D'ARRAS Arras, France
  • Service d'Hématologie, CHU Jean Minjoz Besançon, France
  • Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
  • Institut Bergonié Bordeaux, France
View all 37 locations
View Trial Details
Completed

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

NCT02362035

Conditions
Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

NCT04488354

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

NCT05665530

Conditions
Acute Myeloid Leukemia (AML), Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL), Bone Marrow Diseases, +41 more
Locations
  • City of Hope Duarte, California, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View all 24 locations
View Trial Details
Completed

Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma

NCT04477486

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • NHO Nagoya Medical Center /ID# 221958 Nagoya, Aichi-ken, Japan
  • Aichi Cancer Center Hospital /ID# 221565 Nagoya, Aichi-ken, Japan
  • Kyushu University Hospital /ID# 223299 Fukuoka, Japan
  • Hokkaido University Hospital /ID# 221662 Sapporo, Hokkaido, Japan
View Trial Details

Related conditions